Our result showed that both concurrent and sequential treatment could significantly prolong the CNS‐TTP and OS of NSCLC patients with BM, possibly due to the synergistic effect of EGFR TKI and WBRT 14. This evidence concerns the gene EGFR and non-small cell lung carcinoma.